Mar 17, 2025
In a US FDA-mandated comparative study against a US-approved device, Second Heart Assist Inc. (SHA) validated its Whisper device’s ability to demonstrate significantly lower hemolysis compared to the only approved device on the market today, Johnson & Johnson /...
Dec 13, 2024
Second Heart Assist concludes yet a third highly-successful trial in South America targeted at High Risk PCI that provides solid data on not only safety, but astounding results of efficacy (high-volume perfusion to kidneys, hemodynamic support, ultra-low hemolysis),...
Nov 23, 2024
SALT LAKE CITY, November 19, 2024 /PRNewswire/ — Utah-based Second Heart Assist Inc., announced continued successes in additional clinical studies in South America. Through a series of planned studies, Second Heart Assist has yet again demonstrated significant...
Sep 12, 2024
SALT LAKE CITY, July 25, 2024 /PRNewswire/ — Utah-based Second Heart Assist Inc., announced today the successful completion of the company’s first Central American case to evaluate the performance of its Whisper™ percutaneous mechanical circulatory device....
Sep 12, 2024
In this episode, Zvonimir Krajcer, MD, William “Billy Cohn, MD, and Les Miller, Roubin, MD, discuss the history of ventricular assist devices and future directions of the field of mechanical circulatory support....
